Maleitzke Tazio, Stahnke Katharina, Trampuz Andrej, Märdian Sven
Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Julius Wolff Institute, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Trauma Case Rep. 2019 Jul 15;23:100221. doi: 10.1016/j.tcr.2019.100221. eCollection 2019 Oct.
Mucormycosis is a rare but life-threatening infection, caused by fungi of the Mucorales order, which can be found in soil, rotting leaves or on animals. Through characteristic angioinvasive growth, infections with mucor spores can occur as a pulmonary, rhinocerebral or cutaneous form. Infections mainly affect immunosuppressed patients with a history of uncontrolled diabetes or haematological malignancies, among others. Treatment is multimodal and requires an immediate combination of intravenous amphotericin B therapy and serial surgical debridements. Only a limited number of cases of cutaneous mucormycosis of the hand have been documented and described previously.
We report a cutaneous mucormycosis in an elderly patient with a therapy-resistant acute myeloid leukaemia after a minor trauma on his right hand, sustained whilst gardening. The fungal infection was treated with serial radical debridements, vacuum-assisted negative-pressure wound closure technique and intravenous antifungals. Despite successful eradication of the fungal infection, a palliative open wound care concept was implemented during the terminal course of the patient's leukaemia.
Cutaneous mucormycosis is a rare but fulminant fungal infection mostly affecting immunosuppressed patients. Survival is possible when diagnosed and treated early, yet mortality rates remain high.
毛霉病是一种罕见但危及生命的感染,由毛霉目真菌引起,可在土壤、腐烂树叶或动物身上发现。通过特征性的血管侵袭性生长,毛霉孢子感染可表现为肺部、鼻脑型或皮肤型。感染主要影响有未控制的糖尿病病史或血液系统恶性肿瘤等的免疫抑制患者。治疗是多模式的,需要立即联合静脉注射两性霉素B治疗和系列手术清创。此前仅有有限数量的手部皮肤毛霉病病例被记录和描述。
我们报告一例老年患者,患有治疗抵抗性急性髓系白血病,在园艺时右手受到轻微创伤后发生皮肤毛霉病。真菌感染采用系列根治性清创、负压封闭引流技术和静脉注射抗真菌药物进行治疗。尽管成功根除了真菌感染,但在患者白血病终末期实施了姑息性开放伤口护理方案。
皮肤毛霉病是一种罕见但暴发性的真菌感染,主要影响免疫抑制患者。早期诊断和治疗有可能存活,但死亡率仍然很高。